- Akalabrutinib v léčbě chronické lymfocytární leukemie s autoimunitní hemolytickou anemií2023 | Third Faculty of Medicine
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové